Biodesix, Inc.

BDSX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$42,931-$52,146-$65,447-$43,159
Dep. & Amort.$5,456$5,507$5,844$3,178
Deferred Tax$0$0$0-$2,105
Stock-Based Comp.$6,638$5,373$5,961$4,944
Change in WC-$21,669$11,304-$4,344$4,591
Other Non-Cash$3,857$7,092$13,014$4,328
Operating Cash Flow-$48,649-$22,870-$44,972-$28,223
Investing Activities
PP&E Inv.-$3,230-$22,919-$3,534-$2,547
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$210-$143$0$0
Investing Cash Flow-$3,440-$23,062-$3,534-$2,547
Financing Activities
Debt Repay.-$51$9,951$16,498-$15,350
Stock Issued$55,625$28,126$59,538$16,343
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$3,524-$8,948-$17,154$269
Financing Cash Flow$52,050$29,129$58,882$1,262
Forex Effect$0$0$0$0
Net Chg. in Cash-$39-$16,803$10,376-$29,508
Supplemental Information
Beg. Cash$26,371$43,174$32,798$62,306
End Cash$26,332$26,371$43,174$32,798
Free Cash Flow-$51,879-$45,932-$48,506-$30,770